Our Library

Monkeypox in Australia

Monkeypox has been declared a Communicable Disease Incident of National Significance in Australia. As of 16 August 2022, 82 probable or confirmed cases of monkeypox have been reported to the National Notifiable Diseases Surveillance…

Read more

Longer Acting Paliperidone

Drugline Volume 452

A new presentation of paliperidone is now available on the Pharmaceutical Benefits Scheme (PBS). Invega Hafyera® is a six-monthly injection indicated for the maintenance treatment of adults with schizophrenia. Patients may be eligible for…

Read more

Availability of Trulicity®

DrugAlert Volume 803

HPS Pharmacies wish to advise that Eli Lilly is experiencing a supply interruption for Trulicity® as follows: Trulicity® Pen Dulaglutide (rch) 1.5 mg/0.5 mL ARTG 217965  This supply interruption is due to an unexpected…

Read more

Availability of Ozempic®

DrugAlert Volume 802

HPS Pharmacies wish to advise that Novo Nordisk is continuing to experience a supply interruption for Ozempic® as follows: Ozempic® 0.25/0.5mg Pen Semaglutide 1.34mg/mL ARTG 308324 Ozempic® 1mg Pen Semaglutide 1.34mg/mL ARTG 315107 Supplies…

Read more

Anticholinergic Burden

Background Anticholinergic burden is defined as the cumulative effect of taking multiple anticholinergic medications resulting in an increased risk of adverse effects. High, long-term cumulative exposure has been linked to an increased risk of…

Read more

Availability of Pulmicort® Turbuhaler®

DrugAlert Volume 801

HPS Pharmacies wish to advise that AstraZeneca is experiencing a supply interruption for Pulmicort® Turbuhaler® as follows: Pulmicort® Turbuhaler® Budesonide 200 microgram/ actuation ARTG 10065 Normal supplies of Pulmicort® Turbuhaler® 200mcg are expected to…

Read more
Load More

November 2020

February 2020

Xerostomia (Feb. 27 2020)

Availability of Glucose Intravenous Infusion (Feb. 26 2020)

Availability of Ephedrine Hydrochloride (Feb. 26 2020)

Availability of OsmoLax® (Feb. 26 2020)

Availability of Famotidine (Feb. 26 2020)

Availability of BenPen™ (Feb. 21 2020)

Availability of Carbimazole (Feb. 21 2020)

Availability of Calcium Gluconate Gel (Feb. 21 2020)

Availability of Pindolol (Feb. 21 2020)

Availability of Bleomycin Vials (Feb. 21 2020)

Non-Steroidal Topical Therapy for Dermatitis (Feb. 20 2020)

Availability of Prazosin (Feb. 20 2020)

Availability of Phenoxymethylpenicillin (Feb. 20 2020)

Availability of Dantrolene (Feb. 20 2020)

Availability of Minipress® (Feb. 20 2020)

Availability of Verapamil Tablets (Feb. 19 2020)

Availability of Carafate® Tablets (Feb. 19 2020)

Availability of Pneumovax® 23 (Feb. 18 2020)

Availability of Span-K® Tablets (Feb. 17 2020)

Availability of Irinotecan (Feb. 17 2020)

Defect correction for Palexia® SR 100mg (Feb. 14 2020)

Availability of Haemorol™ (Feb. 14 2020)

Availability of Primacin® (Feb. 14 2020)

Availability of EpiPen® Jr. (Feb. 14 2020)

Monoclonal Antibodies for Migraine (Feb. 13 2020)

Availability of Amoxicillin & Clavulanic Acid Suspension (Feb. 12 2020)

Availability of Emollient Ointment Sterile (Feb. 11 2020)

Availability of Hydroxocobalamin Ampoules (Feb. 11 2020)

Availability of Fleet® Ready-to-Use Enema (Feb. 07 2020)

Availability of Gentamicin Ampoules (Feb. 07 2020)

Availability of Hand Sanitisers (Feb. 07 2020)

Availability of Ciprofloxacin IV (Feb. 07 2020)

Updated PBS-listing for Pembrolizumab in treatment of metastatic non-small cell lung cancer (Feb. 07 2020)

Availability of Zyban® SR Tablets (Feb. 06 2020)

Availability of DBL™ Rocuronium Bromide Vials (Feb. 05 2020)

Availability of Gastrogel Antacid® Oral Suspension (Feb. 05 2020)

Availability of Integrilin® (Feb. 05 2020)

Availability of Tamoxifen Tablets (Feb. 04 2020)

Availability of Ferro-Grad C® Tablets (Feb. 04 2020)

Availability of Minims® Phenylephrine Eye Drops (Feb. 04 2020)

Availability of Panadol® Suppositories (Feb. 04 2020)

Discontinuation of Zantac® Effervescent (Feb. 03 2020)